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Abstract  
GABAA receptors (GABAARs) are ligand-gated Cl
− channels that mediate most of the fast inhibitory 
neurotransmission in the central nervous system (CNS). Multiple GABAAR subtypes are assembled 
from a family of 19 subunit genes, raising the question of the significance of this heterogeneity. In 
this review, we discuss the evidence that GABAAR subtypes represent distinct receptor populations 
with a specific spatio-temporal expression pattern in the developing and adult CNS, being endowed 
with unique functional and pharmacological properties, as well as being differentially regulated at the 
transcriptional, post-transcriptional and translational levels. GABAAR subtypes are targeted to 
specific subcellular domains to mediate either synaptic or extrasynaptic transmission, and their action 
is dynamically regulated by a vast array of molecular mechanisms to adjust the strength of inhibition 
to the changing needs of neuronal networks. These adaptations involve not only changing the gating 
or kinetic properties of GABAARs, but also modifying the postsynaptic scaffold organised by 
gephyrin to anchor specific receptor subtypes at postsynaptic sites. The significance of GABAAR 
heterogeneity is particularly evident during CNS development and adult neurogenesis, with different 
receptor subtypes fulfilling distinct steps of neuronal differentiation and maturation. Finally, analysis 
of the specific roles of GABAAR subtypes reveals their involvement in the pathophysiology of major 
CNS disorders, and opens novel perspectives for therapeutic intervention. In conclusion, GABAAR 
subtypes represent the substrate of a multifaceted inhibitory neurotransmission system that is 
dynamically regulated and performs multiple operations, contributing globally to the proper 
development, function and plasticity of the CNS. 
 
Keywords: diazepam, excitatory–inhibitory balance, gephyrin, neurogenesis, phosphorylation, post-
synaptic density.   
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Introduction 
GABAA receptors (GABAARs) belong to the family of Cys-loop ligand-gated ion channels, along 
with nicotinic acetylcholine receptors, glycine receptors (GlyRs), and serotonin type 3 receptors, 
which form pentameric channels carrying two extracellular ligand-binding sites (Olsen & Sieghart, 
2008). Being permeable to chloride ions, GABAARs mediate most of the inhibitory action of GABA 
in the central nervous system (CNS). By virtue of their ubiquitous expression in neurons (and possibly 
glial cells) (Passlick et al., 2013), GABAARs contribute to all CNS functions, including sensory and 
motor processing, central autonomic control, sleep–wakefulness, emotions, and cognition. Clinically, 
the main relevance of GABAARs relates to their exclusive targeting by benzodiazepines (and other 
ligands with high affinity for the benzodiazepine-binding site), which are used for their anxiolytic, 
sedative, anticonvulsant, and muscle relaxant properties. Benzodiazepine site ligands act as allosteric 
modulators, and, owing to their extraordinary selectivity, produce no other direct action in the CNS. 
GABAARs are also the targets of general anesthetics (Rudolph & Antkowiak, 2004), ethanol, and 
endogenous modulators, notably endozepines (Christian et al., 2013) and neurosteroids (Hosie et al., 
2006). These ligands, in large part derived from glial cells, are considered to be crucial regulators of 
neuronal function and excitability under both physiological and pathological conditions, and 
represent promising novel targets for specific neurological and psychiatric indications [reviewed in 
Belelli & Lambert (2005) and Carver & Reddy (2013)]. 
In the early 1990s, the identification of 19 genes encoding GABAAR subunits (α1–α6, β1–β3, γ1–γ3, 
δ, ε, π, τ, ρ1–ρ3) in mammals, coupled with the demonstration that recombinant receptors assembled 
with an α subunit, a β subunit and the γ2 subunit variant were functionally and pharmacologically 
similar to native GABAARs, raised the question of the significance of GABAAR heterogeneity. This 
question is still largely unresolved, but the evidence available suggests that GABAAR subtypes, 
differing in subunit composition, represent distinct entities with specific functions and 
pharmacological profiles, and with unique spatio-temporal mRNA and protein expression patterns 
(box 1). In this review, we will discuss this evidence, on the basis of four fundamental observations 
made since the existence of GABAAR subtypes was established. 
A first major advance in understanding the function of GABAAR subtypes and the relevance of their 
molecular heterogeneity was the recognition that they mediate two fundamentally distinct forms of 
inhibitory transmission, which depend on their localisation, either postsynaptic (mediating fast, high-
amplitude phasic currents upon quantal presynaptic GABA release) or extrasynaptic [mediating low-
amplitude but persistent (tonic) currents activated by ambient GABA] [reviewed in Farrant & Nusser 
(2005), Belelli et al. (2009), and Brickley & Mody (2012)]. The significance of tonic inhibition, in 
particular for the control of neuronal excitability and plasticity, is now gaining widespread 
recognition. Importantly, these two major populations of GABAARs are molecularly distinct, with 
postsynaptic receptors containing mainly the α1, α2 and α3 subunits, along with β subunit variants 
and the γ2 subunit, and extrasynaptic receptors containing the α4, α5 and α6 subunits, often along 
with the δ subunit (instead of the γ2 subunit). This observation implies that the mechanisms of 
subcellular targeting of GABAAR subtypes are subunit-specific, and can vary between CNS regions 
and developmental stages. The crucial role played by the postsynaptic scaffold organised by gephyrin 
for postsynaptic targeting and confinement of some GABAARs in GABAergic postsynaptic densities 
(PSDs) is now widely recognised, albeit poorly understood (Fritschy et al., 2012; Tretter et al., 2012). 
Furthermore, there is ample evidence for modulation of both postsynaptic and extrasynaptic 
GABAARs by multiple post-translational mechanisms regulating single-channel functional 
properties, trafficking (exocytosis, endocytosis, and degradation), cell surface mobility, and synaptic 
confinement. Thereby, these mechanisms have a major impact on the strength of GABAergic 
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transmission in response to changes in network function, and they represent a major facet of 
GABAergic synapse plasticity (Hines et al., 2011; Luscher et al., 2011a; Connelly et al., 2013a). 
A second major advance was the demonstration, with gene targeting techniques, that the spectrum of 
diazepam's actions is elicited by distinct GABAAR subtypes, distinguished by their α subunit variant 
(Rudolph & Möhler, 2004). The logical consequence of these findings is that these distinct GABAARs 
are localised in different neuronal circuits, even when they are coexpressed within neurons or within 
specific brain areas (Box 2). An important concept emerging in this regard is that GABAergic 
interneurons are likewise specialised to control the activity of principal cells in a circuit-specific 
manner (Klausberger & Somogyi, 2008). This highly sophisticated organisation raises the possibility 
that multiple forms of inhibitory neurotransmission, engaging specific interneurons and GABAAR 
subtypes, operate in parallel in neuronal circuits involved in concurrent tasks. The possibility of 
probing interneuron function in vivo with optogenetic tools has substantially advanced our 
understanding of their role and functional specialisation (Sohal et al., 2009; Pfeffer et al., 2013; Zhu 
et al., 2013). 
A third fundamental insight into GABAAR function is their dependence on ionic mechanisms, 
involving both Cl− and HCO3
− (Blaesse et al., 2009). Therefore, the effects of GABAARs on the 
resting membrane potential, independently of their subunit composition, are determined by the action 
of KCl co-transporters and carbonic anhydrases. It was recognised early that the expression of KCC2, 
the main Cl− extrusion transporter in mature neurons (Kaila, 1994), is developmentally regulated, 
giving rise to the concept of a functional ‘switch’ from depolarising to hyperpolarising GABAAR 
actions during ontogeny (Ben-Ari, 2002), with wide-ranging consequences for our understanding of 
GABA function, as well as the clinical use of GABAAR-modulating drugs in infants (Pavlov et al., 
2013). 
Fourth, it is now well established that GABAAR-mediated transmission regulates multiple steps of 
neuronal development and maturation during ontogenesis and adult neurogenesis, including control 
of stem/precursor cell proliferation, cell fate decision, migration of precursor cells, survival of 
immature neurons, dendritic growth, and synaptogenesis [reviewed in Platel et al. (2007) and Dieni 
et al. (2013)]. Accordingly, it is being increasingly recognised that perturbations of GABAAR 
function during ontogeny or after a lesion, notably during critical periods of plasticity, can have long-
lasting effects on CNS circuit structure and function, potentially contributing to the pathophysiology 
of neurological and psychiatric disorders, including epilepsies, chronic pain, neurodevelopmental 
disorders, mood disorders, and schizophrenia (Bavelier et al., 2010; Lewis, 2012). 
Here, we will review the relevance of GABAAR heterogeneity for the regulation of GABAergic 
neurotransmission and GABAergic synaptic plasticity, and its potential impact on the 
pathophysiology of major neurological and psychiatric diseases, notably disorders linked to abnormal 
GABAergic function during brain development. We will highlight recent progress and discuss major 
roadblocks on the way to better understanding the diversity of GABAAR regulation in health and 
disease. To do so, we will briefly introduce the molecular heterogeneity of GABAergic synapses, 
prior to discussing mechanisms regulating GABAARs in the context of GABAergic synaptic 
plasticity. Next, we will highlight the relevance of GABAAR subtypes for the regulation of neuronal 
development, and finally, their relevance for the pathophysiology of neurological and psychiatric 
diseases linked to abnormal GABAergic transmission. 
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Composition and localisation of major GABAAR subtypes 
The subunit composition of major GABAAR subtypes is well established at a regional level 
(immunoprecipitation with extracts from the whole brain or a specific brain region), and there is 
general agreement that the most likely subunit stoichiometry is 2α/2β/γ (the last of these being 
sometimes substituted by δ or ε) (Boileau et al., 2005; Olsen & Sieghart, 2008; Patel et al., 2013). 
The existence of receptors containing α and β subunits only, as well as receptors with other 
stoichiometries (e.g. 2α/β/2γ and 2α/β/2ε), is probable (Jones & Henderson, 2013). Furthermore, the 
rules governing the formation of pentameric complexes are far from being fully elucidated. 
Functional GABAARs, with the pharmacological profile of native receptors, are formed by 
pentameric assembly of 2α/2β/γ2, where the α and β subunits can be either identical or different. The 
γ2 subunit can be substituted by γ1 or γ3 subunits (present at low levels and/or with a restricted 
expression pattern) or by δ, and possibly ε, subunits. There is consensus, therefore, that at least 36 
distinct GABAAR subtypes exist in CNS neurons (Olsen & Sieghart, 2008). In vitro expression of β 
and γ subunits only, or targeted deletion of an α subunit gene in vivo, prevent the assembly and/or 
surface targeting of a functional GABAAR complex, thereby providing the opportunity to remove 
specific GABAAR subtypes by inactivating a single α subunit gene (Box 1). 
The most detailed information on the regional distribution of 18 GABAAR subunit mRNAs in the 
mouse brain, determined by non-radioactive in situ hybridisation with cellular resolution, is available 
in the Allen Brain Atlas (http://mouse.brain-map.org). These data confirm the findings of original 
studies on the distribution of abundant subunits (α1–α6, β1–β3, and γ2) (Laurie et al., 1992; Wisden 
et al., 1992), and provide detailed information on subunits expressed either at low levels in numerous 
regions throughout the neuraxis, such as the γ3 subunit, or at high levels in specific regions, such as 
the ε subunit in the amygdala, basal forebrain, locus coeruleus, and other noradrenergic cell groups. 
According to the Allen Brain Atlas, the ρ1 and ρ2 subunit mRNAs (corresponding to GABAC 
receptors) are restricted to the superficial layers of the superior colliculus, and the π subunit mRNA 
is undetectable in the adult mouse brain. 
Immunohistochemically, the distribution of 10 subunits (α1–α6, β2, β3, γ2, and δ) has been analysed 
in detail, at the regional and, sometimes, cellular level, and validated by targeted gene deletion 
(Fritschy & Mohler, 1995; Nusser et al., 1999; Peng et al., 2002; Chandra et al., 2006; Hörtnagl et 
al., 2013). There is also information available for β1 and γ1 subunits that confirms the in situ 
hybridisation data. According to these studies, it is very apparent that the six α subunit variants largely 
correspond to distinct GABAAR subtypes [notwithstanding the possibility of finding two different α 
subunits in a substantial fraction of GABAARs (Balic et al., 2009)] – each with a specific distribution 
pattern that overlaps only partially with that of other α subunits (Fig. 1). The same holds true for the 
β subunit variants, with the β2 and β3 subunits overlapping to a large extent with the α1 and α2 
subunits, respectively (whereas the β1 unit is expressed at lower levels in numerous brain regions). 
The γ2 subunit, in line with its association with the vast majority of GABAAR subtypes, is 
ubiquitously expressed; in contrast, the γ1 subunit appears to have a highly restricted distribution, 
being most abundant in the hypothalamus, amygdala, and parts of the basal ganglia, as well as the 
inferior olivary nucleus. Finally, the δ subunit, which forms GABAAR located extrasynaptically (Box 
3), largely overlaps with the α4 subunit in the forebrain and with the α6 subunit in the cerebellum.  
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Figure 1. Differential distribution of GABAAR α subunit variants in the adult mouse forebrain. (A–E) Each panel depicts 
in false colors (increasing intensity: dark blue, red, orange, yellow, and white) the relative staining intensity pattern of 
each subunit indicated, as determined by immunoperoxidase staining. The α6 subunit is not depicted, because it is not 
expressed in the forebrain. Note that each subunit has a unique distribution pattern, with partial overlap and 
complementarity to other α subunits. (F) Main anatomical structures present in the images of A–E. ac, anterior 
commissure; AON, anterior olfactory nucleus; CA1, CA1 region of the hippocampus; cc, corpus callosum; CPu, caudate 
nucleus and putamen (= striatum); DG, dentate gyrus; GPe, globus pallidus, external; IC, inferior colliculus; nRT, 
thalamic reticular nucleus; OB, olfactory bulb; Pi, piriform cortex; Po, pontine nuclei; S1, primary somatosensory cortex; 
SC, superior colliculus; SNr, substantia nigra, pars reticulata; Su, subiculum; VP, ventral pallidum; VPL, ventral postero-
lateral thalamic nucleus. Scale bar: 2 mm. Adapted from Panzanelli et al. (2011). 
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So far, however, there are only a few CNS regions in which the GABAAR subunit repertoire and their 
cellular/subcellular distribution have been analysed in some detail by immunohistochemistry. These 
include the hippocampal formation (notably the CA1 subfield, which shows remarkable 
heterogeneity, with expression of at least 11 subunits), the neocortex, the olfactory bulb, parts of the 
thalamus (notably, the ventrobasal complex, lateral geniculate nucleus, and reticular nucleus), the 
cerebellum, and the spinal cord dorsal horn. 
 
 
 
 
Box 1. Limitations of immunohistochemistry for studying GABAARs 
Whereas GABAARs are pentameric protein complexes, immunohistochemistry only allows the 
visualisation of individual subunits, each of which belongs to several subtypes. Furthermore, as the 
pentamer contains two α subunits and two β subunits, it is not possible in neurons expressing 
multiple α or β subunit variants to determine whether they belong to the same receptor, or to distinct 
receptors with a similar subcellular distribution. Therefore, the exact GABAAR subtype repertoire 
of any neuron type is not established [see, for example, Panzanelli et al. (2011)]. A further 
limitation is that, so far, there are no antibodies suitable for immunochemistry for some of the 
GABAAR subunits. In particular, very little information is available for the distribution of the γ1, 
γ3, ε, π and τ subunit proteins, or for the ρ1–ρ3 subunits, at either a regional, cellular or subcellular 
level. As a result, several GABAAR subtypes, probably with atypical pharmacology and a highly 
selective distribution, remain poorly characterised, and their contribution to inhibitory transmission 
in these specific CNS areas is unknown. 
Besides these limitations, it should be emphasised that, although immunohistochemistry reveals 
the detailed distribution and relative staining intensity of each subunit across the CNS, this method 
does not allow quantitative comparisons between antibodies (and thus assessment of the abundance 
of a given subunit relative to other subunits), because the affinity of antibodies for their epitopes, 
and their accessibility in tissue sections prepared for histology, cannot be directly measured. 
Furthermore, in the light of evidence showing that the specificity and sensitivity of the 
immunohistochemical procedure critically depends on epitope accessibility (Lorincz & Nusser, 
2008), each antibody should be tested with various antigen retrieval methods. This is particularly 
important to interpret a lack of staining for a specific antibody in some regions and to accurately 
determine the subcellular distribution of GABAARs. 
This latter point is of crucial relevance for understanding the functional organisation of the 
GABAergic system. Functional and biochemical studies differentiate among several pools of 
GABAARs in neurons, being localised intracellularly (reflecting biosynthesis, metabolism, and the 
reserve pool) or at the cell surface, postsynaptically or extrasynaptically (Box 3). 
Immunohistochemical studies have shown that the detection of postsynaptic GABAARs is greatly 
impaired by aldehyde fixation, and requires alternative methods to the classic transcardial 
perfusion. Therefore, immunohistochemical analysis of GABAAR subunit distribution provides 
different results according to the fixation method used. Furthermore, we had noted in our initial 
report (Fritschy & Mohler, 1995) that the cellular distribution pattern of GABAARs revealed by 
each antibody across brain regions is highly variable, ranging from diffuse staining of the neuropil 
to ‘Golgi-like’ staining of a few neurons, outlining their entire dendritic tree. This feature makes it 
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impossible to quantify with a single densitometric parameter the abundance of a subunit in a given 
brain region, as it can vary widely between various cell types. 
Therefore, analyses of regional distribution patterns, showing marked differences in subunit 
abundance across different anatomical structures of the CNS, need to be complemented with 
methods allowing cellular and subcellular resolution to map GABAAR subtypes in a synapse-
specific manner, and to derive some quantitative measurement of relative receptor abundance. We 
have recently reported a method allowing concurrent visualisation of postsynaptic GABAARs with 
high sensitivity and resolution and biochemical analysis of brain tissue from the same animal 
(Notter et al., 2013). In the future, new methods will have to be devised to unequivocally detect 
presynaptic GABAARs, whose existence is well established functionally, but whose distribution in 
axons remains largely elusive. 
The limitations of immunohistochemistry are even more evident for ultrastructural studies, in 
which the sensitivity of the method is reduced by the strong fixation required for ultrastructural 
preservation. It was recognised early on that pre-embedding immune-electron microscopy is not 
suitable for the detection of GABAARs at postsynaptic sites (Somogyi et al., 1989). Post-
embedding techniques, notably following tissue embedding in Lowicryl, enabled this problem to 
be circumvented, but have low sensitivity and have been successful with only a limited number of 
subunits (Nusser et al., 1995; Somogyi et al., 1996; Panzanelli et al., 2004). More recently, the 
development of sodium dodecylsulfate digestion after freeze–fracture has enabled substantial 
progress by allowing the three-dimensional visualisation and quantification of GABAARs in the 
plasma membrane (Kasugai et al., 2010), albeit with a limited number of antibodies. 
 
 
 
 
 
 
 
At the subcellular level, a distinction between postsynaptic and extrasynaptic GABAARs can be made, 
based on the appearance of staining in weakly fixed tissue (Box 1). Postsynaptic receptors form 
brightly stained clusters, which co-localise with postsynaptic markers, such as gephyrin and 
neuroligin 2 (NL2), and are apposed to vesicular GABA transporter (VGAT)-positive presynaptic 
terminals (Fig. 2A). The remainder of the staining, besides these clusters, represents receptors 
dispersed at the cell surface, as well as the metabolic pool of receptors localised in the cytoplasm. 
Extrasynaptic receptors fail to form clusters, and the staining is of uniform intensity, with a ‘powdery’ 
appearance in the neuropil, suggesting a widespread distribution on dendritic branches (Fig. 2B). 
Accordingly, these structures show no obvious relationship with the distribution of either gephyrin 
or GABAergic axon terminals (Fig. 2B). As discussed below, presynaptic receptors localised in axons 
and axon terminals represent a distinct subset of extrasynaptic receptors, with specialised functions. 
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Figure 2. Distinction between postsynaptic and extrasynaptic GABAARs by immunofluorescence staining and confocal 
laser scanning microscopy. The subcellular localisation is based on the identification of postsynaptic sites positive for 
gephyrin (geph) and presynaptic GABAergic terminals positive for VGAT. (A) α2 subunit staining in the adult mouse 
CA1, revealing numerous brightly stained clusters around pyramidal cell bodies in the stratum pyramidale (sp) and on 
their dendrites in the stratum oriens (so) and radiatum (sr). (A1–A4) High-magnification images taken from a section 
triple-stained for the α2 subunit (red), gephyrin (yellow) and VGAT (blue) in the stratum radiatum, showing, with single, 
double and triple staining, that α2 clusters are co-localised with gephyrin (A3; yellow) and apposed to VGAT-positive 
terminals (A2). (B) α5 subunit staining in the adult mouse CA1, showing the granular appearance of the staining, with 
pyramidal cells in the stratum pyramidale appearing as lightly stained structures with an unstained nucleus. (B1–B4) At 
higher magnification, the granular staining lacks bright clusters (as seen for α2 in A1) and shows no obvious relationship 
with gephyrin clusters (B3; green) or VGAT-positive terminals (B4; blue). Scale bars: A and B, 20 μm; A1–A4 and B1–
B4, 5 μm. Adapted from Panzanelli et al. (2011). 
 
 
 
 
 
Despite scant morphological evidence from immunohistochemical studies, there is strong functional 
support for the existence of GABAARs located on axons and presynaptic terminals (Grasshoff et al., 
2007; Trigo et al., 2008; Long et al., 2009; Witschi et al., 2011). A prominent exception is a 
population of GABAARs, readily detected immunohistochemically for the presence of the α2 subunit, 
located on the axon initial segment of cortical neurons, typically clustered in rows of synapses 
innervated by axo-axonic interneurons (Nusser et al., 1996; Fritschy et al., 1998; Panzanelli et al., 
2011). Functionally, these GABAARs correspond to postsynaptic receptors anchored by gephyrin, 
and their activation contributes to the genesis of γ-oscillations (Tukker et al., 2007). In contrast to 
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those on axo-axonic synapses, most presynaptic GABAARs located on distal axons and terminals are 
hardly detectable by immunohistochemistry. They nevertheless play a key role in the control of axon 
potential transmission, neuronal synchronisation, regulation of transmitter release, and mediation of 
presynaptic afferent depolarisation (Trigo et al., 2008; Long et al., 2009; Ruiz et al., 2010; Wakita et 
al., 2013). Although their subunit composition is unknown, it might be inferred from the repertoire 
of subunit mRNAs expressed by the cell of origin of these axons. We have recently characterised a 
population of GABAARs on primary afferent terminals in the spinal cord, containing α2 and α3 
subunits, that are crucially involved in the anti-hyperalgesic action of diazepam (Witschi et al., 2011; 
Paul et al., 2012). 
 
 
 
Box 2. Lessons from GABRA-KO and GABRA-knock-in mice: GABAAR subtypes have specific 
roles 
Targeted deletion of a GABAAR subunit gene, especially when constitutive, can lead to important 
changes in the distribution and expression pattern of the remaining subunits, suggestive of 
compensatory adaptations. For example, GABRA1-KO (α1-KO) mice show upregulation of α2-
GABAARs and α3-GABAARs in regions where the α1 subunit is abundant (Kralic et al., 2006; 
Zeller et al., 2008); δ-KO mice show increased α4 subunit expression, associated with the γ2 
subunit, and with an altered subcellular distribution (Peng et al., 2002). Typically, however, the 
receptor subtype that is missing as a consequence of the deletion is not merely ‘replaced’ by another 
subtype present in the same cell. This feature is particularly striking in neurons expressing a 
mixture of postsynaptic and extrasynaptic receptors. Deletion of the α subunit variant present in 
the postsynaptic receptors leads to their disappearance (and a corresponding loss of postsynaptic 
currents), whereas the extrasynaptic receptors remain either unchanged, or increased (Kralic et al., 
2006; Peden et al., 2008). Therefore, the inability of α4-GABAARs to cluster at postsynaptic sites 
is not attributable to competition with other receptor subtypes. In neurons expressing multiple 
postsynaptic receptors, synapse-specific rearrangements occur, but there is no replacement of the 
missing receptor, as seen, for example, in CA1 pyramidal cells of α2-KO mice, where α1-
GABAARs remain unaffected in perisomatic synapses, but disappear from the axon initial segment 
(Panzanelli et al., 2011). Some striking forms of compensation have been reported, which remain 
unexplained. Thus, in thalamic reticular neurons of α3-KO mice, immunohistochemistry reveals 
the apparent loss of postsynaptic GABAARs and gephyrin, but these mutants show larger 
postsynaptic currents than wild-type mice (Schofield et al., 2009). 
These observations lend support to the contention that GABAAR subtypes, defined by their subunit 
composition, are unique functional entities, fulfilling specific roles, and are not interchangeable 
within a given type of neuron. This contention received further support from the analysis of H101R 
knock-in mice, engineered to remove the diazepam-binding site located at the α/γ interface of the 
pentameric complex, without affecting assembly, cell surface trafficking, regulation or gating of 
the receptor (Rudolph et al., 1999; Löw et al., 2000; Crestani et al., 2002; Yee et al., 2005). 
Behavioral analysis of histidine to arginine knock-in mice for each the four α subunit variants 
assembled in diazepam-sensitive GABAARs revealed a loss of specific effects of diazepam, which 
allowed classification of the contribution of each subtype to the spectrum of diazepam's effects. 
Thus, sedation involves only α1-GABAARs, whereas anxiolysis occurs upon allosteric modulation 
of α2-GABAARs, and, when stress is involved, partially α3-GABAARs [reviewed in Rudolph & 
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Möhler (2004)]. More recent studies have shown a corresponding segregation of other effects of 
diazepam (and midazolam), including benzodiazepine addiction (Tan et al., 2010), tachypnea 
(Masneuf et al., 2012), and anti-hyperalgesia (Knabl et al., 2008), to specific GABAAR subtypes. 
Importantly, electrophysiological analyses confirmed that the point mutations are functionally 
silent. However, in α5(H105R) mutants, the mutation leads to decreased expression of α5-
GABAARs, which is behaviorally significant (Prut et al., 2010) (Box 3). 
Distinction between GABAAR subtypes based on the β subunit variants is less straightforward, in 
particular because each β subunit can be associated with various α subunits. Nevertheless, β3 
subunit-containing GABAARs selectively mediate the action of intravenous general anesthetics, as 
well as some of the effects of pentobarbital, as shown in β3(N265M) mutant mice (Jurd et al., 
2003; Zeller et al., 2007). In addition, neuron-specific deletion of these receptors curtails survival 
beyond early postnatal age in the majority of mutant mice (Ferguson et al., 2007). 
Taken together, these findings are of fundamental relevance not only for the development of 
efficacious benzodiazepine site ligands devoid of unwanted side-effects (in particular, sedation), 
but also to investigate how neuronal circuits are assembled during brain development and regulated 
by plasticity mechanisms in adulthood. 
 
 
 
Molecular organisation of GABAergic synapses 
The subcellular localisation of GABAARs is intimately linked to the molecular organisation of 
GABAergic synapses, with specific proteins of the PSD contributing to trafficking and anchoring 
GABAARs in a subtype-specific manner. It was recognised early that GlyRs, which are homologous 
to GABAARs, are localised at postsynaptic sites (Triller et al., 1985), owing to their high-affinity 
binding to the scaffolding protein gephyrin (Pfeiffer et al., 1982; Kirsch et al., 1993), which interacts 
with the cytoskeleton. The demonstration that the majority of postsynaptic GABAARs also are 
clustered with gephyrin took longer (Sassoè-Pognetto et al., 1995, 2000), in part because gephyrin 
was considered to be present only at glycinergic synapses, and in part because GABAARs do not bind 
gephyrin with high affinity. On the basis of the evidence available to date, the α1, α2 and α3 subunits, 
as well as possibly the β2 and β3 subunits, can interact directly with gephyrin via motifs located in 
their main intracellular loop (Tretter et al., 2008, 2011; Mukherjee et al., 2011; Kowalczyk et al., 
2013), and can therefore be clustered postsynaptically. Conversely, GABAARs containing the α4, α5 
or α6 subunit are localised predominantly extrasynaptically (Nusser et al., 1998; Chandra et al., 2006; 
Panzanelli et al., 2011). The α4 and α6 subunits – as well as the α1 subunit in specific interneurons 
(Mann & Mody, 2010; Milenkovic et al., 2013) – are frequently associated with the δ subunit, which 
substitutes for the γ2 subunit (Box 3). However, extrasynaptic vs. postsynaptic targeting of 
GABAARs appears to depend on motifs present in α subunit variants, as seen by comparing 
recombinant α2-GABAARs and α6-GABAARs containing either γ2 or δ subunits (Wu et al., 2012). 
The finding that targeted deletion of the γ2 subunit abolishes postsynaptic clustering of both 
GABAARs and gephyrin highlighted the interdependence between receptors (rather than individual 
subunits) and the gephyrin scaffold in proper localisation at the cell surface (Essrich et al., 1998; 
Schweizer et al., 2003). Likewise, targeted deletion of Gphn (encoding gephyrin) confirmed its key 
role in postsynaptic clustering of GlyRs and GABAARs (Feng et al., 1998). These observations 
triggered intense research on the functions of gephyrin and the identification of proteins regulating 
GABAAR trafficking and GABAergic synapse formation [reviewed in Luscher et al. (2011a), 
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Fritschy et al. (2012), and Tretter et al. (2012)]. These molecules include, in particular, collybistin, a 
Rho-GEF identified as a direct binding partner of gephyrin, mediating its translocation to the cell 
surface (Kins et al., 2000), NL2, which interacts trans-synaptically with neurexin isoforms 
(Varoqueaux et al., 2004; Kang et al., 2008) (Fig. 3), and an array of proteins regulating GABAAR 
biogenesis, cell surface trafficking, endocytosis, and degradation (Jacob et al., 2008; Luscher et al., 
2011a; Vithlani et al., 2011). 
 
 
 
 
 
Figure 3. Schematic depiction of major postsynaptic proteins interacting with GABAARs and their putative organisation 
in the PSD of a GABAergic synapse (see main text for details). (A) Schematic depiction of key molecules of GABAergic 
synapses. (B) Possible arrangement of gephyrin molecules, forming trimers as proposed from structural analysis (Sander 
et al., 2013), and models of the scaffolding assembly, to which GABAARs and collybistin bind. (C) Basic molecular 
organisation of the GABAergic PSD, showing the presence of NL2 (interacting with presynaptic neurexin isoforms and 
with gephyrin), collybistin splice variants, in both active and inactive conformations, and interacting with the small 
GTPases CDC-42 and/or TC-10, in addition to gephyrin and GABAARs. The exact roles of collybistin, and its enzymatic 
activity, remain hypothetical; the scheme shows a proposed function for gephyrin submembrane targeting, along with 
possible effects within the PSD itself to facilitate recruitment of GABAARs moving via lateral diffusion in the membrane. 
The size of each molecule is depicted roughly relative to its molecular mass. CB, collybistin; PIP3, phosphatidylinositol 
3,4,5-trisphosphate.  
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Gephyrin 
This phylogenetically ancient, highly conserved multifunctional molecule is responsible throughout 
the kingdom of life for Moco biosynthesis (Stallmeyer et al., 1999). Moco activates molybdenum 
enzymes, whose functions are essential for survival (Schwarz et al., 2009). Gephyrin comprises two 
main catalytic domains (G and E), which, in bacteria, are encoded by two distinct genes (MogA and 
MoeA); in plants, the domains are fused, and in vertebrates, they are interconnected by a flexible 
linker (or central domain), which carries numerous sites for post-translational modifications and 
interaction with partner proteins [reviewed in Fritschy et al. (2008)]. The domain organisation of 
mammalian gephyrin not only ensures optimal Moco synthesis, but has also allowed the emergence 
of novel, neuron-specific functions for the regulation of GlyR and GABAAR clustering (Belaidi & 
Schwarz, 2013). Whereas the structure of gephyrin is not fully resolved, current evidence suggests 
the formation of trimers (Sander et al., 2013), which organise themselves in a highly ordered 
supramolecular complex anchoring GABAARs in the plasma membrane and interacting with effector 
proteins (including NL2 and collybistin) and the cytoskeleton (Fig. 3) [reviewed in Tyagarajan & 
Fritschy (2014)]. 
Postsynaptic clustering of gephyrin by auto-aggregation at GABAergic (and glycinergic synapses) 
represents a process that is fundamentally different from scaffold formation in the PSD of 
glutamatergic synapses, where PSD-95 and its homologs assemble a modular scaffold and interact 
with their partners by means of the PDZ interaction domain (Kennedy, 2000; Sheng & Sala, 2001). 
In GABAergic PSDs, most proteins lack a PDZ domain; therefore, there must be molecular 
mechanisms specifically enabling gephyrin scaffold formation at postsynaptic sites. Identifying these 
mechanisms is complicated by the fact that biochemical purification of GABAergic PSDs has not 
been achieved so far, whereas glutamatergic PSDs are highly enriched in synaptosomal fractions 
(Husi & Grant, 2001). Therefore, there are, as yet, only limited proteomic data on inhibitory PSDs 
(Heller et al., 2012), and the possibility exists that major players involved in scaffold formation and 
regulation at GABAergic synapses have not yet been identified. 
A major insight from recent studies was the finding that post-translational modifications of gephyrin, 
mainly via phosphorylation, regulate its clustering properties, and thereby the structural and 
functional properties of GABAergic synapses (Tyagarajan & Fritschy, 2014). This regulation is 
coupled to complex interactions with collybistin and NL2 (see below), contributing to GABAergic 
synapse formation and their dynamic regulation by activity-dependent mechanisms. Therefore, 
gephyrin emerges as a key element of a signaling hub regulating GABAergic function and plasticity 
in health and disease. 
It is of note that postsynaptic gephyrin clustering is not an intrinsic property of this protein, but 
depends strictly on the presence of GABAAR subtypes with which gephyrin (and possibly additional 
proteins) can interact. Therefore, the loss of postsynaptic currents in α1-knockout (KO) and α2-KO 
mice also leads to disruption of gephyrin postsynaptic clustering (Fritschy et al., 2006; Kralic et al., 
2006; Pallotto et al., 2012). Despite these crucial bidirectional interactions, gephyrin-independent 
GABAAR clustering at postsynaptic sites has been observed, both in vitro and in vivo (Kneussel et 
al., 2001; Levi et al., 2002; Panzanelli et al., 2011), pointing to alternative pathways regulating their 
synaptic localisation. One of these mechanisms might be afforded by the dystrophin–glycoprotein 
complex, which is present selectively in a subset of GABAergic synapses in cortical neurons and 
cerebellar Purkinje cells [reviewed in Fritschy et al. (2012)]. Indeed, we have shown in α2-KO mice 
that postsynaptic clusters of α1-GABAARs and NL2 remain selectively associated with the 
dystrophin–glycoprotein complex, but not with gephyrin, in perisomatic synapses of CA1 pyramidal 
cells (Panzanelli et al., 2011). A possible molecular link holding these proteins together is provided 
by the synaptic scaffolding molecule, which interacts with both dystrophin and NL2 (Sumita et al., 
2007). Interestingly, the cell adhesion molecule IgSF9b, which interacts with the synaptic scaffolding 
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molecule and NL2, has recently been shown to promote the formation of GABAergic synapses, in 
particular in cortical interneurons, where it is most strongly expressed (Woo et al., 2013). 
A recent study using super-resolution microscopy to analyse the molecular organisation of inhibitory 
PSDs provided a first quantification of the number of gephyrin molecules present per synapse, and 
demonstrated that the numbers of both GlyRs and GABAARs at the synapse depend on gephyrin 
abundance (Specht et al., 2013). A possible difference in the molecular organisation of these synapses 
emerged from the observation that silencing neuronal cultures with tetrodotoxin for 48 h affected the 
synaptic enrichment of GABAARs, but not of GlyRs. 
 
 
 
Box 3. Extrasynaptic GABAARs 
Tonic inhibition, mediated by persistent activation of extrasynaptic GABAARs, is an important 
determinant of neuronal excitability, and is increasingly being recognised as playing a key role in 
mediating the effects of neurosteroids, and contributing to the pathophysiology of major disease 
states [reviewed in Belelli et al. (2009), Gunn et al. (2011), and Brickley & Mody (2012)]. 
Although tonic inhibition is widely considered to reflect receptor activation by ambient GABA, 
this concept has been questioned by evidence that spontaneous opening of GABAARs might 
contribute to most of the tonic currents that can be recorded in dentate gyrus granule cells 
(Wlodarczyk et al., 2013). Extrasynaptic receptors containing the δ subunit have a very high 
affinity for GABA, and mediate most actions of neurosteroids, thus contributing to the regulatation 
of brain activity under circumstances when their synthesis is increased, including stress, delivery, 
and ethanol intoxication (Sarkar et al., 2011; Carver & Reddy, 2013). These receptors are 
selectively modulated by the super-agonist gaboxadol (but are insensitive to classic benzodiazepine 
agonists) (Mortensen et al., 2010). Until recently, it was unclear how the expression and cell surface 
expression of extrasynaptic receptors is regulated. Evidence now indicates that tonic inhibition in 
the dentate gyrus and thalamus is modulated by protein kinase A and protein kinase C (PKC) 
activity (targeting α4-GABAAR) (Connelly et al., 2013a), e.g. upon stimulation of GABABRs 
(Connelly et al., 2013b; Tao et al., 2013). Specifically, PKC-mediated phosphorylation of Ser443 
in the α4 subunit was shown to enhance the cell surface expression and activity of these receptors 
(Abramian et al., 2010). However, another study contended that PKC activation reduces tonic 
inhibition in the thalamus by targeting the β2 subunit (Bright & Smart, 2013). As tonic inhibition 
is a major determinant of neuronal excitability, these data indicate novel, albeit contradictory, 
mechanisms that potentially have major effects on network activity. 
Besides α4/β/δ receptors, α5-GABAARs (most probably composed of α5, β3 and γ2 subunits) also 
form a prominent population of extrasynaptic receptors in the hippocampal formation, olfactory 
bulb, and cerebral cortex. These receptors are modulated by diazepam, but are insensitive to 
zolpidem. Interest in these receptors was triggered by the observations in α5(H105R) mutant mice 
(carrying diazepam-insensitive α5-GABAARs; see Box 2) that they do not develop tolerance to the 
sedative (i.e. motor-impairing) action of diazepam (van Rijnsoever et al., 2004). Furthermore, 
α5(H105R) mutant mice showed an approximately 30% reduction in α5-GABAARs but showed 
improved performance in a hippocampus-dependent memory task (trace fear conditioning) as 
compared with wild-type mice (Crestani et al., 2002). This observation opened the tantalising 
perspective that reducing the function of α5-GABAARs might be exploited to reverse disease-
related deficits in cognition and memory performance, and triggered the search for inverse agonists 
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acting selectively at these receptors [reviewed in Rudolph & Möhler (2013)]. However, a more 
systematic analysis of α5(H105R) mutant mice revealed increased basal locomotion and altered 
memory for the location of objects, indicative of hippocampal dysfunction (Prut et al., 2010). 
Therefore, the reduced expression of α5-GABAAR induces complex bidirectional changes in 
behavioral performance in these mutants. 
Other receptors, presumably containing the γ2 subunit, as revealed by their sensitivity to diazepam, 
are located extrasynaptically and mediate tonic inhibition. They include, in particular, α3-
GABAARs in the basolateral amygdala (Marowsky et al., 2012) and the inferior olivary nucleus 
(Devor et al., 2001). The rules governing the extrasynaptic localisation of these receptors are not 
understood. The majority of α3-GABAARs, notably in thalamic reticular neurons or in hippocampal 
or cerebellar interneurons, form postsynaptic clusters associated with gephyrin (Studer et al., 2006; 
Schneider Gasser et al., 2007; Notter et al., 2013). Whereas interactions with gephyrin are thought 
to be crucial for postsynaptic receptors, other mechanisms, remaining to be explored, might 
supersede them to determine (and maintain) α3-GABAARs at extrasynaptic sites in specific neuron 
populations. A similar dichotomy exists for α5-GABAARs, which are not strictly extrasynaptic in 
the hippocampal formation (Serwanski et al., 2006); those located extrasynaptically were shown 
to interact with radixin, a phosphoprotein belonging to the ezrin–radixin–meosin protein family 
and interacting with the actin cytoskeleton (Loebrich et al., 2006). 
 
 
 
 
Collybistin 
Collybistin is a neuron-specific guanine nucleotide exchange factor that activates the small Rho 
GTPases CDC-42 and TC-10 (Mayer et al., 2013), and binds gephyrin at an identified site. Loss of 
GABAAR and gephyrin clustering occurs in a cell type-specific manner in collybistin-KO mice, 
showing the essential function of this protein at GABAergic synapses (Papadopoulos et al., 2007, 
2008). The effect can be reproduced in cultured neurons upon overexpression of a collybistin isoform 
that is unable to interact with membrane phospholipids (via its PH domain) (Reddy-Alla et al., 2010; 
Tyagarajan et al., 2011a). In these experiments, expression of constitutively active CDC-42 restored 
gephyrin clustering, indicating that it probably operates downstream of collybistin (Tyagarajan et al., 
2011a). However, elucidating the function(s) of collybistin and its effectors is complicated by the 
existence of collybistin splice variants, carrying or lacking an N-terminal SH3 domain (collybistinSH3+ 
and collybistinSH3-, respectively), because collybistinSH3+ has been reported to be an inactive form that 
needs to be activated in order to contribute to gephyrin and GABAAR clustering (Poulopoulos et al., 
2009). The nature of this activation presumably involves a conformational change that enhances 
binding of the PH domain to membrane phospholipids (Fig. 3). It has been proposed, for example, 
that binding of the GABAAR α2 or α3 subunit to collybistin, in conjunction with gephyrin, facilitates 
gephyrin cluster formation (Saiepour et al., 2010). Likewise, binding of NL2 to the SH3 domain was 
suggested to activate collybistin and thereby enable gephyrin clustering (Poulopoulos et al., 2009). 
However, targeted deletion of the NL2 gene (NLGN2) does not abolish gephyrin clustering, and 
collybistin overexpression in neurons strongly stimulates gephyrin clustering independently of the 
presence or absence of the SH3 domain (Chiou et al., 2011; Tyagarajan et al., 2011a), suggesting 
alternative mechanisms. Among these, the small GTPase TC-10 was recently shown to activate 
collybistin upon interaction with the PH domain, thereby enhancing gephyrin clustering in cultured 
neurons (Mayer et al., 2013).  
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NL2 
There are four neuroligin isoforms encoded by distinct genes (NLGN1–NLGN4) (Bolliger et al., 
2001). These proteins, anchored postsynaptically by means of a single transmembrane domain, 
interact with presynaptic neurexins. This interaction is strongly synaptogenic, even in non-neuronal 
cells, upon overexpression in vitro (Scheiffele et al., 2000; Graf et al., 2004; Chih et al., 2005). NL2 
is selectively located at GABAergic synapses (Varoqueaux et al., 2004) and neuroligin 4 at 
glycinergic synapses (Hoon et al., 2011) [but see Soto et al. (2011)], whereas neuroligin 1 is selective 
for glutamatergic synapses (Song et al., 1999), and neuroligin 3 is found in both glutamatergic and 
GABAergic synpases (Budreck & Scheiffele, 2007). Neuroligins have drawn considerable attention 
because they are associated with autism-spectrum disorders and other forms of mental retardation 
[reviewed in Südhof (2008)], as well as schizophrenia (Sun et al., 2011). Their specific in vivo role 
is not yet fully elucidated, in part because of functional redundancy with other synaptogenic 
molecules (Varoqueaux et al., 2006), and because their functions (and localisation) are modulated by 
complex interactions with neurexin isoforms (Futai et al., 2013), post-translational modifications 
(Peixoto et al., 2012; Suzuki et al., 2012; Giannone et al., 2013), homodimerisation, and 
heterodimerisation (Poulopoulos et al., 2012; Shipman & Nicoll, 2012). In particular, it is not known 
whether neuroligins interact directly with GABAARs. Nevertheless, NL2-KO mice show a specific 
reduction in the number of perisomatic GABAergic synapses in principal neurons of the hippocampal 
formation, associated with a decrease in inhibitory currents and increased network excitability 
(Jedlicka et al., 2011). 
It should be noted that, whereas NL2 is generally considered to be upstream in the chain of molecular 
events leading to the formation of GABAergic synapses (Dong et al., 2007; Poulopoulos et al., 2009), 
in vitro evidence indicates that overexpression of GABAAR alone in non-neuronal cells (lacking 
collybistin and, presumably, gephyrin) is sufficient to generate functional contacts, generating 
inhibitory postsynaptic currents (Fuchs et al., 2013). 
Functional regulation of GABAAR subtypes: significance for GABAergic synapse 
plasticity 
GABAARs are regulated by ubiquitous transcriptional and post-translational processes, as well as by 
multiple protein–protein interactions. As discussed above with regard to their interactions with 
gephyrin, there is considerable subtype specificity in the regulation of GABAARs, which allows 
neurons expressing several receptor subtypes to make fine, synapse-specific adjustments in response 
to a large array of extrinsic and intrinsic signals. Here, we will discuss the regulation of GABAAR 
subtypes in mature neurons, focusing on four major aspects. 
Transcriptional control of GABAAR subunit expression 
The gene structure and chromosomal localisation of human (and rodent) GABAARs are well 
established (Simon et al., 2004), and their promoter sequences and binding sites for transcription 
factors and regulatory elements are being subjected to intense scrutiny [reviewed in Steiger & Russek 
(2004)]. However, little is known about how the subunit repertoire of any given neuron is determined 
during development, although models explaining the coordinated expression of subunits located in 
gene clusters (e.g. β2–α1–γ2–α6) have been proposed (Uusi-Oukari et al., 2000; Joyce, 2007). 
Remarkable variability in the abundance of mRNAs encoding the 19 GABAAR subunits has been 
found in both mice and humans, with considerable regional specificity, and being under the control 
of multiple gene regulatory mechanisms (Mulligan et al., 2012). In addition, there is strong evidence 
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for transcriptional regulation of GABAAR subunits by neurosteroids, as well as in a number of 
pathological conditions, including epilepsy, ethanol intoxication, Alzheimer's disease, and 
schizophrenia [reviewed in Steiger & Russek (2004) and Grabenstatter et al. (2012)]. A recent genetic 
study identified a chromosomal duplication in a locus encoding four GABAAR subunits (4p12: α2, 
α4, β1, and γ1) that is associated with neurodevelopmental disorders (Polan et al., 2013). In contrast, 
it is not well established whether the compensatory increase in subunit expression observed in some 
GABAAR subunit-KO mice (Box 1) reflects transcriptional control or is attributable to changes in 
mRNA stability and/or post-translational mechanisms (Peng et al., 2002; Kralic et al., 2006; Ogris et 
al., 2006). The issue is of relevance, because these compensatory changes contribute to the 
maintenance of homeostatic balance between excitation and inhibition in the mutant mice. 
Transcriptional control of GABAAR subunit expression would probably involve activity-dependent 
mechanisms targeting specific transcription factors (or possible non-coding RNAs), and would need 
to deal with the regulation of local translation in dendrites (Cajigas et al., 2012). 
Post-translational modifications of GABAARs 
Membrane anchoring of GABAARs is regulated by palmitoylation of the γ2 subunit, and this 
mechanism contributes to the normal formation and function of GABAergic synapses (Fang et al., 
2006). In addition, it is well established that multiple phosphorylation mechanisms, targeting various 
GABAAR subunits, play a key role in modulating the efficacy of GABAergic transmission, either by 
changing single-channel gating or kinetic properties, or by regulating stability, cell surface delivery, 
or internalisation of GABAARs [reviewed in Jacob et al. (2008), Houston et al. (2009), Luscher et al. 
(2011a), and Vithlani et al. (2011)]. Combined with recent reports that gephyrin phosphorylation at 
Ser268 and Ser270 by glycogen synthase kinase-3β and extracellular signal-related kinase, 
respectively, is a negative regulator of GABAergic transmission (Tyagarajan et al., 2011b, 2013; Rui 
et al., 2013), these data indicate that multiple signaling pathways can dynamically modulate neuronal 
excitability by activating protein kinases or phosphatases, as well as their downstream effectors. As 
phosphorylation events on GABAARs are subunit-specific, differential effects can be expected for 
various GABAAR subtypes, even within the same neuron. Furthermore, considering the tight 
functional coupling between the gephyrin scaffold and postsynaptic GABAARs, the question arises 
of whether phosphorylation of gephyrin and GABAARs is coordinated. As gephyrin carries multiple 
consensus sites for phosphorylation (and other post-translational modifications, such as acetylation 
and SUMOylation) (Tyagarajan & Fritschy, 2014), the response to this question awaits their further 
characterisation. In addition, it is conceivable that the gephyrin scaffold serves to anchor protein 
kinases (and phosphatases) acting on GABAARs, and therefore regulates the efficacy of receptor post-
translational modifications. 
A major advance in our understanding of the in vivo significance of GABAAR phosphorylation is 
provided by the generation of knock-in mice carrying point mutations that abolish the 
phosphorylation of residues known to be targeted by protein kinases in vitro. However, these studies 
have shown unexpectedly strong effects of the mutations, with the γ2 Y365F/Y367F mutation being 
embryonically lethal, and inducing in heterozygous mice sex-specific increases in tonic inhibition 
(α4/δ-GABAΑRs) to compensate for reduced neurosteroid sensitivity in the thalamus (Jurd & Moss, 
2010; Nani et al., 2013). 
Regulation of GABAAR trafficking and cell surface diffusion 
Membrane insertion (and internalisation) of GABAARs occurs at extrasynaptic sites, followed by 
lateral diffusion and reversible trapping in the postsynaptic membrane (Bogdanov et al., 2006), 
suggesting dynamic regulation of phasic inhibition from a reserve pool of extrasynaptic receptors 
(Thomas et al., 2005). Furthermore, preventing docking of GABAARs at endocytotic zones in the 
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plasma membrane – by interfering with a binding motif located in the intracellular loop of the β3 
subunit – blocked GABAAR internalisation, as well as downregulation following oxygen–glucose 
deprivation, which is a model of ischemia in vitro (Smith et al., 2012). Such observations underscore 
the fact that regulated diffusion of GABAARs in the plasma membrane is of prime relevance under 
physiological and pathophysiological conditions. 
Single-particle tracking studies have also revealed that GABAAR mobility at the cell surface and at 
postsynaptic sites is tightly regulated by activity-dependent mechanisms and differential interactions 
with gephyrin (Bannai et al., 2009; Shrivastava et al., 2011; Niwa et al., 2012). Thus, postsynaptic 
and extrasynaptic GABAARs have similar diffusion rates in the plasma membrane, but the former 
remain confined in GABAergic postsynaptic sites for longer, and their trapping depends on the 
presence of the gephyrin scaffold (Mukherjee et al., 2011; Renner et al., 2012). Increasing synaptic 
activity, leading to Ca2+ influx, reduced the amplitude of miniature inhibitory postsynaptic currents 
(mIPSCs), owing to dispersion of GABAARs to extrasynaptic sites by a mechanism involving the 
protein phosphatase calcineurin (Bannai et al., 2009). Recent evidence indicates, however, that this 
activity-dependent Ca2+ influx also affects the gephyrin scaffold, although dispersion of GABAARs 
and dispersion of gephyrin occur on different time scales, partially independently of each other (Niwa 
et al., 2012). Together with previous evidence (Muir et al., 2010), these results indicate that cross-
talk between excitatory and inhibitory transmission occurs via the activation of Ca2+-dependent 
signaling events that impinge on both GABAARs and the postsynaptic scaffold. Much remains to be 
determined about how these phenomena observed in vitro are mediated in vivo, and whether they 
selectively affect specific GABAAR subtypes in cortical principal cells or cause global effects across 
various types of synapse. 
Regulation of GABAAR-mediated transmission by neurotrophins and metabolic factors 
Neurotrophins, such as brain-derived neurotrophic factor (BDNF), have major effects on excitatory 
synaptic plasticity, mediated by multiple signaling pathways downstream of TrkB. It is therefore no 
surprise that BDNF also regulates the strength of GABAAR-mediated transmission, by acting on both 
GABAergic synapse formation (Chen et al., 2011) and plasticity: BDNF produces bi-phasic effects 
on GABAAR-mediated transmission, reflecting its action on cell surface expression (Brünig et al., 
2001; Jovanovic et al., 2004). In a recent study, the possibility has been raised that BDNF acutely 
causes internalisation of α1-GABAARs in the amygdala by causing rapid gephyrin degradation (Mou 
et al., 2013). However, long-lasting enhancement of GABAAR-mediated transmission in the 
hippocampus, owing to enhanced cell surface expression, has been shown to arise from 
phosphorylation of Tyr657 and Tyr367 in the γ2 subunit (Vithlani et al., 2013); the significance of 
this modulation, as tested in γ2(Y365F/Y367F) knock-in mice, is an anti-depressant behavioral 
phenotype and increased hippocampal neurogenesis, raising the possibility that GABAAR 
phosphorylation regulates the anti-depressant action of BDNF. 
We have recently uncovered a novel mode of GABAAR regulation, activated by reactive oxygen 
species (ROS), and therefore by cellular metabolism (Accardi et al., 2014). In this study, blocking 
the mitochondrial respiratory chain or elevating intracellular ROS levels in cerebellar interneurons 
caused a gradual increase in the frequency of mIPSCs, owing to the appearance of additional low-
amplitude currents with slow decay kinetics. Whereas the majority of mIPSCs in these cells are 
mediated by α1-GABAARs, these newly induced currents had the kinetic properties of α3-GABAARs, 
and, indeed, depended on expression of the α3 subunit in these cells, as tested in α3-KO mice (whereas 
deletion of the α1 subunit had no effect on this phenomenon). Along with evidence that the effects of 
ROS elevation are attributable to postsynaptic adaptations, rather than presynaptic changes in 
transmitter release, these results suggested that ROS activate a signaling cascade leading to the 
selective recruitment of α3-GABAARs to either ‘silent’ synapses, or to synaptic contacts formed de 
novo from terminals known to form multiple release sites (Accardi et al., 2014). In line with these 
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results, insulin acutely increases GABAAR cell surface expression in vitro (Wan et al., 1997), but it 
has not been established whether the same mechanism is involved. 
Significance for GABAergic synapse plasticity 
The main conclusion derived from studies of GABAAR (and gephyrin) post-translational regulation 
is that GABAergic synapses represent dynamic entities regulated by multiple mechanisms to 
homeostatically adjust the responsiveness and function of neuronal networks according to changes in 
their environment. These regulatory adjustments concern both postsynaptic and extrasynaptic 
receptors, and involve multiple intracellular signaling cascades. We have speculated elsewhere that, 
by means of its role as scaffolding protein, gephyrin might interact with various effectors to adjust 
the structure and function of GABAergic synapses over a considerable dynamic activity range 
(Tyagarajan & Fritschy, 2014), thereby ensuring homeostatic synaptic plasticity in mature neuronal 
circuits. 
Post-translational regulation of GABAARs (and gephyrin) is implicated in the functional plasticity of 
GABAergic synapses, as demonstrated in several systems [reviewed in Kullmann et al. (2012)]. For 
example, a well-studied model is rebound potentiation at inhibitory synapses of cerebellar Purkinje 
cells, which is induced by depolarisation of Purkinje cells, and involves Ca2+ influx and activation of 
Ca2+/calmodulin kinase 2 (Kano et al., 1996). Rebound potentiation involves trafficking of 
GABAARs to enhance their surface expression, and is necessary for adaptation of the vestibule-ocular 
reflex, a form of Purkinje cell-dependent motor learning (Kawaguchi & Hirano, 2007; Tanaka et al.). 
In addition to functional plasticity, regulation of GABAARs also contributes to structural plasticity 
by inducing changes in GABAergic synaptic connectivity. For example, chronic treatment of Ts65Dn 
mouse mutants, a model of Down syndrome, with a selective α5-GABAAR negative allosteric 
modulator reduced the density of GABAergic synapses in the hippocampal formation and normalised 
behavior (Martínez-Cué et al., 2013). 
GABAAR heterogeneity in times of change: CNS development and adult 
neurogenesis 
Developmental changes in GABAAR subunit expression 
GABAARs are expressed at early stages of fetal brain development by neural precursor cells and 
during neuronal differentiation, and have been proposed to regulate cell proliferation, migration, and 
differentiation, possibly through Ca2+-mediated signals activated by neuronal depolarisation 
[reviewed in Represa & Ben-Ari (2005), Cellot & Cherubini (2013), and Lu et al. (2014)] (Box 4). 
Accordingly, one might expect developmental deficits in the CNS of GABAAR subunit-KO mice, 
notably with regard to subunits that are highly expressed in fetal brain. However, among the targeted 
deletions analysed so far (α1–α6, β2, β3, δ, and γ2), no detectable alterations in brain general 
architecture at birth have been reported, suggesting the existence of compensatory mechanisms 
substituting for the missing receptor subtype. Therefore, the absence of phenotype in these mutant 
mice should not be taken as evidence that GABAARs are dispensable for regulating brain 
development. Rather, they might be so important that functional redundancy has been developed to 
prevent deleterious effects in the case of dysfunction of a given subtype. 
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Box 4. GABAAR-mediated ‘excitation’ 
As GABAARs are selectively permeable for Cl
− and HCO3
− (Kaila, 1994), there is now a large 
consensus that elevation of the intracellular concentration of either species might result in a 
depolarising current upon GABAAR activation, and thereby potentially ‘excite’ this neuron 
(Blaesse et al., 2009). There is ample evidence for GABAAR-mediated depolarisation of immature 
(and mature) neurons and NG2 cells, leading to Ca2+ influx, opening the door to speculation about 
the role of Ca2+ as a second messenger in these cells, in particular to control the cell cycle and 
differentiation mechanisms (Tanaka et al., 2009; Merz et al., 2011; Young et al., 2012). It has also 
been proposed that GABAAR-mediated excitation precedes (and is replaced by) glutamatergic 
transmission during the maturation of cortical neurons (Hennou et al., 2002), and that ‘excitatory’ 
GABA drives giant depolarising potentials, which are network phenomena thought to contribute to 
proper axonal wiring of the developing CNS [reviewed in Dehorter et al. (2012)]. 
The reality of GABAAR-mediated excitation in vivo has been much debated, as have its functional 
significance and the main ion species responsible for it. In particular, there is often confusion about 
the excitatory effects of depolarising GABA, considering that one of the main effects of GABAAR 
activation is a net increase in membrane conductance, opposing the depolarising effect of positive 
charge influx induced by any other neurotransmitter. Therefore, whereas a neuron can be 
depolarised by GABA, this does not necessarily translate into it being ‘excited’. 
The prevalent view is that GABA-induced depolarisation is attributable to high expression of the 
co-transporter NKCC1 and low expression of KCC2, which exert opposing actions on intracellular 
Cl−. Nevertheless, in mature neurons (expressing high levels of KCC2), intense GABAAR 
stimulation can lead eventually to neuronal depolarisation caused by KCC2-mediated K+ efflux 
(Viitanen et al.,2010). This bi-phasic response, which involves short-lasting changes in the ionic 
driving force of GABAAR and reduces the efficacy of diazepam (Deeb et al., 2013), has been 
coined ‘short-term ionic plasticity’ (Raimondo et al., 2012). Despite the importance of NKCC1 
and KCC2 for regulating GABA function, in particular under pathological conditions such as 
epilepsy and chronic pain, little is known about their precise subcellular localisation and functional 
regulation. Evidence is now emerging that transcriptional and post-translational mechanisms, 
involving, among other factors, BDNF signaling, have major impacts on the availability and cell 
surface expression of KCC2 (Yeo et al., 2009; Lee et al., 2011; Puskarjov et al., 2012; Chamma et 
al., 2013; Sun et al., 2013). Furthermore, it is now being recognised that, besides NKCC1 and 
KCC2, the developmental maturation of carbonic anhydrases is a major determinant of the driving 
force of GABAARs in the immature brain (Rivera et al., 2005). Thus, the absence of carbonic 
anhydrase (upon targeted gene deletion) enhances the depolarising action of GABA and induces 
seizures in neonatal mice (Ruusuvuori et al., 2013). Finally, it should be emphasised that, despite 
initial speculations that the depolarising and hyperpolarising effects of GABA might be mediated 
by distinct GABAAR subtypes, there is no evidence supporting this possibility. These speculations 
were triggered, in part, by observations that the subunit composition of major GABAAR subtypes 
changes drastically, in particular in the neocortex and thalamus, during the phase of synaptogenesis 
(see main text). However, this subunit switch appears to be unrelated to GABA depolarisation, and 
its significance remains a matter of speculation. 
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It is well established that the subunit composition of the predominant GABAAR subtypes changes 
during the period of synaptogenesis, accounting in part for the distinct functional and 
pharmacological properties of GABAARs in neonatal and mature brain (Fritschy et al., 1994; Paysan 
et al., 1997; Hutcheon et al., 2000; Bosman et al., 2002; Fagiolini et al., 2004; Peden et al., 2008; 
Hashimoto et al., 2009). Nevertheless, there is only fragmentary information on the expression pattern 
of GABAAR subunits in neural precursor cells and immature neurons. mRNA in situ hybridisation 
data available in the Allen Brain Atlas (http://mouse.brain-map.org) show a predominance of α2, α3, 
α5, β2, β3 and γ2 subunits at embryonic day 18.5. As this stage precedes synaptogenesis, one might 
assume that these receptors are mainly engaged in tonic, possibly depolarising, GABAergic 
transmission. In particular, the α5 subunit is strongly expressed perinatally, and its expression 
decreases during synaptogenesis, except in regions where it remains abundant in the adult brain 
(hippocampal formation, olfactory bulb, and brainstem). It is of note that downregulation of the α5 
subunit in layer 4 of the neocortex and its replacement by the α1 subunit have been shown to be 
dependent on the integrity of thalamocortical projections (Paysan et al., 1997), providing an attractive 
model with which to study the mechanisms underlying transcriptional and post-transcriptional control 
of subunit expression. In contrast to the α5 subunit, other subunits defining the main extrasynaptic 
GABAARs of the adult brain (α4, α6, and δ) are absent or expressed at low levels in the fetal brain, 
and are upregulated when neuronal maturation nears completion. In the human neocortex, the 
GABAergic system develops during the second half of pregnancy and in infancy (Xu et al., 2011), 
and the expression of GABAAR subunit genes appears to be coordinated on the basis of their 
respective chromosomal localisations (Fillman et al., 2010), with distinct upregulation and downregu-
lation patterns suggestive of differential expression of specific GABAAR subtypes. 
To elucidate why the pattern of GABAAR subunit expression evolves during ontogeny, considerable 
attention has been given to α1-GABAARs, which are upregulated in a region-specific manner during 
the phase of synaptogenesis to become the predominant GABAAR subtype present in the adult CNS 
(Fritschy et al., 1994; Paysan et al., 1994; Hashimoto et al., 2009). As these receptors typically show 
fast decay kinetics and generate large-amplitude events (Eyre et al., 2012), their gradual appearance 
was taken as evidence for maturation of GABAergic function (Vicini et al., 2001; Bosman et al., 
2002), in particular to endow postsynaptic neurons with fast-acting receptors matching the high firing 
rate of certain interneurons. Furthermore, as discussed in the next paragraph, α1-GABAARs on 
perisomatic synapses of cortical pyramidal cells enable critical windows of plasticity (Fagiolini et al., 
2004). Similar, but reversible, changes in subunit expression have been proposed to account for the 
plasticity of GABAergic transmission in the supraoptic nucleus during gestation and after delivery 
(Brussaard et al., 1997). However, there is evidence from several electrophysiological studies that 
the acceleration of mIPSC kinetics occurring during brain development or following hormonal 
fluctuations does not depend solely on the subunit composition of GABAARs (Koksma et al., 2003, 
2005; Peden et al., 2008). Rather, post-translational modifications mechanisms affecting GABAAR 
gating properties, and possibly their trafficking and interactions with scaffolding proteins, might also 
play a role in defining their gating properties. 
To fully understand how differential expression of GABAARs shapes the functional properties of 
GABAergic transmission, it will be essential to also determine the developmental GABAAR 
expression profile in interneurons, as these receptors will have a key role in the maturation and 
determine the firing properties of input cells controlling synaptic circuits. 
GABAAR subtype setting critical periods of plasticity 
The seminal observation that the time of opening of critical period windows (during which sensory 
deprivation causes lasting structural and functional alterations) can be delayed or advanced by 
reducing or enhancing GABAergic transmission provided direct evidence for the fundamental role 
played by GABAAR-mediated transmission in regulating cortical development (Hensch et al., 1998; 
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Fagiolini & Hensch, 2000). Further investigations unambiguously showed that this effect requires a 
highly specific cortical circuit (Katagiri et al., 2007), involving a central role for large parvalbumin-
positive basket cells, which control the output of principal cells by activating α1-GABAARs 
[reviewed in Hensch (2005)]. Evidence for the key role played by these receptors was provided by 
the demonstration that diazepam is unable to advance the opening of a critical period window in 
α1(H101R) mice (Fagiolini et al., 2004). 
GABA is not the only neurotransmitter involved in this process, as modulation of nicotinic 
acetylcholine receptors by targeted deletion of Lynx1, a membrane-anchored prototoxin that 
negatively regulates nicotinic acetylcholine receptor function (Ibañez-Tallon et al., 2002), allows re-
opening of critical period windows in adulthood; remarkably, this effect of Lynx1 deletion can be 
blocked by co-application of diazepam, demonstrating that a balance between excitation and 
inhibition, rather than the action of a single transmitter, is the determinant for setting the opening and 
closing of critical period windows (Morishita et al., 2010). 
The relevance of parvalbumin-positive basket cells in setting network configurations that are 
permissive for structural and functional plasticity, and that are required for learning and memory 
acquisition, is not restricted to critical period windows, but appears to be a fundamental principle of 
brain plasticity (Donato et al., 2013), involving a canonical pattern of interconnections between 
interneurons (Pfeffer et al., 2013). According to these experiments, inhibitory control of parvalbumin-
positive basket cells by vasoactive intestinal peptide-positive interneurons is low in mice exposed to 
conditions permissive for learning (e.g. enriched environment) and high when either a new task is 
acquired or when adverse conditions (e.g. fear conditioning) lead to memory retention. Remarkably, 
the maturation and strength of inhibitory control of parvalbumin-positive basket cells is regulated by 
the transcription factor Otx2. This secreted molecule requires binding to a specific receptor in 
perineuronal nets – which selectively surround parvalbumin-positive interneurons – for cell 
penetration and activation of gene transcription (Beurdeley et al., 2012). 
Taken together, these results underscore the fact that GABAergic transmission in the developing brain 
(and during permissive phases of plasticity that are critical for learning and circuit refinement) is 
regulated by sophisticated mechanisms, and mediated by specific circuits containing defined 
GABAAR subtypes, such as α1-GABAARs in synapses formed on principal cells by parvalbumin-
positive basket cells. 
Regulation of adult neurogenesis 
By analogy with brain development, GABAARs expressed by stem cells, neural precursor cells and 
immature neurons contribute to the proliferation, migration, differentiation and synaptic integration 
of adult-born neurons [reviewed by Overstreet et al. (2005), Ge et al. (2007), Sernagor et al. (2010), 
and Nissant & Pallotto (2011)]. Likewise, as in developing neurons, GABA initially exerts 
depolarising effects on precursor cells (Box 4), activating Ca2+-dependent mechanisms that have 
enduring effects on precursor cell migration, cell survival, and subsequent neuronal maturation 
(Overstreet et al., 2005; Ge et al., 2006; Jagasia et al., 2009; Chancey et al., 2013). 
Adult neurogenesis, taking place in the subventricular zone of the lateral ventricles and in the 
subgranular zone of the dentate gyrus, represents an important facet of brain plasticity regulated by 
GABAergic mechanisms. Experimentally, it offers an attractive paradigm for investigating the role 
of GABAAR-mediated regulation of neuronal maturation and functional integration into pre-existing 
synaptic circuits. Thus, analysis of the consequences of GABAAR inactivation in radial glia-like stem 
cells revealed that local parvalbumin-positive fast-spiking interneurons in the dentate gyrus determine 
their mode of division (symmetric vs. asymmetric) as well as neuronal vs. glial fate (Song et al., 
2012); furthermore, the pharmacological profile of these receptors (zolpidem-insensitive) is 
compatible with expression of α5-GABAAR in these stem cells. In relation to this, investigating the 
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role of extrasynaptic (α4 and δ) and postsynaptic (α2) GABAARs inactivated by gene targeting, we 
have provided evidence that these GABAAR subtypes regulate distinct phases of adult neurogenesis 
in the dentate gyrus (Duveau et al., 2011). In line with findings that GABA exerts negative control 
on neural precursor cell proliferation (Platel et al., 2007), α4-KO mice showed increased 
neurogenesis. No phenotype was seen in δ-KO mice, as expected from the delayed expression of this 
subunit during ontogeny [but see Whissell et al. (2013)]. Ablation of α4-GABAARs also impaired 
dendritic growth and the final positioning of adult-born granule cells; in contrast, α2-KO newborn 
neurons showed delayed pruning of dendritic branches, presumably to maintain inhibitory–excitatory 
balance upon maturation of glutamatergic inputs (Duveau et al., 2011). 
A more dramatic phenotype was observed upon selective α2 subunit inactivation in adult-born 
olfactory bulb granule cells (Pallotto et al., 2012), which represent the main interneuron subtype of 
the olfactory bulb, being continuously generated from mitotic precursor cells in the subventricular 
zone (Carleton et al., 2003). As α2-GABAARs provide most synaptic inhibition to these cells, their 
inactivation profoundly altered dendritic development, spine formation, and the maturation of 
glutamatergic inputs. Also, modulation of dendritic differentiation by environmental enrichment or 
deprivation, which is prominent in wild-type adult-born granule cells (Saghatelyan et al., 2005), was 
abrogated in adult-born α2-KO granule cells (Pallotto et al., 2012). The severity of these effects 
underscores the central role played by GABAARs in regulating neuronal differentiation. Moreover, 
these results, taken together, provide an exquisite demonstration that GABAAR subtypes are 
specialised for specific tasks, with considerable spatio-temporal specificity. 
Significance for CNS disorders 
Elucidation of the molecular organisation and regulation of GABAAR subtypes opens new 
perspectives for understanding pathophysiological mechanisms in neurological and psychiatric 
diseases, and for developing treatment approaches that go beyond symptomatic relief. Key aspects of 
the possible involvement of GABAAR-mediated transmission in the pathophysiology of CNS 
disorders lie in their contribution to developmental processes and dependence on Cl− and HCO3
− 
fluxes (Box 4). In turn, GABAAR dysfunction can be determined genetically, and/or depend on 
abnormal regulation and trafficking. Here, we briefly discuss these mechanisms in the light of a few 
selected examples. 
GABAAR subunit mutations are typically associated with generalised, mostly idiopathic epilepsies 
and Dravet syndrome. They have been described in α, β3, γ2 and δ subunits. Although the data are 
somewhat controversial, the majority of these mutations impair the trafficking and cell surface 
expression of GABAARs, as well as their diffusion dynamics in the plasma membrane, and hence 
their postsynaptic clustering (Bouthour et al., 2012) [reviewed in Galanopoulou (2010) and 
Macdonald et al. (2010)]. Some of these effects have been proposed to be temperature-dependent, 
hence providing a plausible cause of febrile seizures. However, the general picture emerging from 
these studies is that GABAAR mutations cause multiple molecular and biochemical alterations that 
are not easily related to specific symptoms of disease, notably epileptogenesis and seizure occurrence, 
thereby reflecting the complexity of the mechanisms underlying epileptic syndromes. 
GABAAR mutations have also been associated with other CNS pathologies. For example, although 
the complex interactions between ethanol intoxication or ethanol dependence and GABAARs go 
beyond the scope of this review, it is worth mentioning that a dominant point mutation in the β1 
subunit (L285R), which causes spontaneous channel opening and strongly enhances tonic inhibition 
in the nucleus accumbens, was shown recently to induce severe spontaneous ethanol consumption in 
mice (Anstee et al., 2013). In the same study, the selective contribution of β1-containing GABAARs 
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was confirmed by a second mutation, which resulted in a similar behavioral phenotype. These data 
underscore the main contention of this review, namely how dysfunction of specific GABAAR 
subtypes, affecting a minor subpopulation of receptors, can cause strong behaviorally relevant effects. 
Brain lesions, such as stroke or temporal lobe epilepsy with hippocampal sclerosis, lead to 
pathological alterations in GABAergic tonic inhibition, owing to overexpression or a reduction in 
expression of specific GABAAR subtypes [reviewed in Hines et al. (2011), Grabenstatter et al. (2012), 
and Houser et al. (2012)]. In a seminal study investigating the relevance of tonic inhibition in stroke, 
Clarkson et al. showed that reducing tonic inhibition in the peri-infarct area, a zone that is of crucial 
importance for functional recovery, with infusion of a benzodiazepine inverse agonist, or by 
genetically reducing the expression of extrasynaptic GABAARs, promoted functional recovery 
(Clarkson et al., 2010). These data are well in line with evidence that GABAergic transmission 
regulates neuronal plasticity by setting the inhibitory–excitatory balance in neuronal networks. 
GABAAR-mediated transmission during brain development has been linked to the emergence of 
neurodevelopmental disorders, as well as adult-onset diseases that depend on the proper formation of 
neuronal circuits, such as schizophrenia and depression (Luscher et al., 2011b; Lewis, 2012; Marín, 
2012). Similarly, abnormal GABAergic transmission during critical periods of development can 
cause severe sensory deficits, such as amblyopia, and can impair sensorimotor and cognitive 
development; importantly, understanding the underlying mechanisms provides clues for therapeutic 
intervention (Bavelier et al., 2010). Table 1 lists four principal mechanisms through which altered 
GABAergic transmission during CNS development and maturation has been implicated in brain 
diseases. In most cases, alterations can be traced back to mutations affecting neuronal maturation, 
synapse formation, and/or signaling cascades. As GABAAR-mediated transmission and inhibitory–
excitatory balance regulate key steps of neuronal migration and differentiation, the effects can be 
enduring. Thus, conditional inactivation of one γ2 subunit allele at defined stages of brain maturation 
induces either depression-like or anxiety-like behaviors in adult mice (Shen et al., 2012). Although 
the underlying mechanisms are not yet fully elucidated, they comprise alterations in adult 
neurogenesis in the dentate gyrus, and changes in the synaptic connectivity and function of specific 
interneurons, notably fast-spiking parvalbumin-positive basket cells and somatostatin-positive 
interneurons. The crucial role played by interneurons in the proper development of GABAergic 
synaptic connections is underscored by the long-ranging consequences of cell type-specific 
conditional gene deletions, such as inactivation of ErbB4 in parvalbumin-positive cortical 
interneurons, which affects the formation of axo-axonic synapses and synchronisation between the 
prefrontal cortex and the hippocampal formation, leading to a schizophrenia-like phenotype (Del Pino 
et al., 2013). In humans, a corresponding deficit in axo-axonic synapses in the prefrontal cortex is 
selectively found in schizophrenia but not bipolar disorder, and is accompanied by compensatory 
upregulation of the α2 subunit in the axon initial segment of pyramidal cells [reviewed in Lewis & 
Hashimoto (2007)]. 
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Table 1. Consequences of altered GABAergic function for neurodevelopmental and psychiatric disorders 
Possible causes Functional consequences Functional deficit, disorder Selected references 
Reduced GABA synthesis, 
defective maturation of 
interneurons, altered 
excitatory–inhibitory 
balance 
Abnormal 
opening/duration of critical 
windows of plasticity 
Sensory, motor or cognitive 
(e.g. language) deficits 
Hensch (2005), 
Ehninger et al. 
(2008), Bavelier et 
al. (2010) 
Mutations affecting 
extracellular matrix proteins, 
synapse formation, and 
transcription factors; 
defective neurotrophin 
signaling 
Abnormal neuronal 
migration, interneuron 
differentiation, synapse 
formation (e.g. axon initial 
segment) 
Epilepsy, schizophrenia 
Lewis et al. (2005), 
Galanopoulou 
(2010); Heinrich et 
al. (2011), Marín 
(2012) 
Mutations affecting genes 
involved in synaptogenesis 
(e.g. NLGN genes), defective 
postsynaptic scaffold 
formation and intracellular 
signaling, impaired 
excitatory–inhibitory 
balance 
Altered intracellular 
signaling, impaired 
dendrite development and 
spine maturation, reduced 
synaptic plasticity 
Intellectual disabilities, 
Angelman syndrome, autism-
spectrum disorders 
Südhof (2008), 
Blundell et al. 
(2009), Shen & 
Scheiffele (2010), 
Pizzarelli & 
Cherubini (2011) 
Altered expression of 
GABAAR subunit genes, 
early-life stress, defective 
BDNF signaling 
Abnormal GABAAR 
function at critical stages 
of brain development 
Anxiety disorders, major 
depression 
Hong et al. (2008), 
Maguire & Mody 
(2009), Shen et al. 
(2012), Smith 
(2013), Vithlani et 
al. (2013) 
 
 
The analysis of knock-in mice expressing diazepam-insensitive GABAAR subtypes (Box 2) has 
noticeably expanded the catalog of potential therapeutic applications of benzodiazepine site ligands, 
provided that subtype specificity and differential efficacy can be achieved with novel compounds 
[reviewed in Rudolph & Möhler (2013)]. These studies also implicate potential dysfunction of 
GABAARs in a broader set of diseases than those treated with classic benzodiazepine site ligands. 
Thus, α2-GABAARs not only mediate diazepam anxiolysis, but also contribute to anxiety-related 
behaviors elicited by exposure to novelty and mild threat, as shown in α2-KO mice (Koester et al., 
2013). These receptors also contribute to mood disorders and chronic pain, and polymorphisms in 
GABRA2 have been linked to alcohol dependence and drug abuse (Engin et al., 2012). In chronic 
pain, the anti-hyperalgesic action of benzodiazepine site ligands devoid of sedative liability occurs 
primarily via stimulation of α2-GABAARs in primary afferents and in the spinal cord dorsal horn, 
without involving supra-spinal sites (Witschi et al., 2011; Paul et al., 2013). α5-GABAARs, as noted 
in Box 3, regulate learning and memory, as well as hippocampal neurogenesis, and represent a 
promising target for improving cognitive performance in Down syndrome patients. These receptors 
have also been implicated in memory deficits associated with acute neuroinflammation, possibly 
because interleukin-1β increases their cell surface expression in hippocampal neurons (Wang et al., 
2012). Considering the multiple post-translational mechanisms regulating GABAAR-mediated 
transmission, the latter finding opens the possibility that multiple chemokines and cytokines might 
affect GABAergic transmission by activating the underlying signaling pathways. Therefore, one 
might speculate that GABAARs contribute extensively to the mediation of neuro-immune 
interactions.  
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Conclusions and perspectives 
This review discusses the evidence that GABAARs form multiple subtypes, endowed with specific 
functional and pharmacological properties and being differentially regulated by multiple 
mechanisms, at the levels of both gene expression and protein modification. Furthermore, we 
underscore that this regulation does not operate in isolation, but is intimately linked to the regulation 
of the postsynaptic scaffold organised by gephyrin, thereby vastly enlarging the repertoire of 
mechanisms that dynamically contribute to fine-tuning GABAergic transmission in response to 
various extracellular and intracellular signals. From this perspective, GABAAR-mediated 
transmission appears as a multifaceted process that is fundamental to proper brain development, 
function, and plasticity. The analysis of the specific role of GABAAR subtypes reveals their 
involvement in the pathophysiology of major CNS disorders, and opens novel perspectives for 
therapeutic intervention, notably based on subtype-specific ligands, and/or targeting specific 
signaling pathways regulating GABAergic synapse function. 
Whereas the concept of GABAAR subtype, with a well-defined subunit composition and functional 
properties, holds well in the adult brain, it is more difficult to define (and test) during brain 
development, when synaptic transmission is not yet present, and most effects of GABA are mediated 
by autocrine or paracrine mechanisms. In particular, there are no behavioral readouts with which to 
probe the consequences of altered GABAAR function in developing animals, and the significance of 
the major changes in subunit expression taking place during synaptogenesis remains unexplored. 
Nevertheless, the evidence available, in particular from studies of critical window plasticity and of 
adult neurogenesis (during which developmental processes are re-initiated in adult brain), provides 
strong support for the contention that GABAAR subtypes are tailor-made to modulate highly specific 
steps of neuronal differentiation and circuit formation during CNS ontogeny. 
Several GABAAR subtypes, composed of ‘rare’ subunits (γ1, γ3, ε, π, and τ), remain to be 
characterised. Their restricted localisation in specific brain regions (notably the hypothalamus and 
the basal forebrain) and their non-conventional pharmacological profile offer opportunities for 
selective intervention to regulate specific brain functions, notably related to the neuro-endocrine axis, 
sleep–wake regulation, and central autonomic function. However, these distant perspectives will first 
require the development of analytical tools (and genetically engineered mice) to probe the function 
of these so far overlooked GABAAR subtypes. 
The major focus given recently to ‘extrasynaptic’ receptors, notably those containing the δ subunit, 
follows the same logic to exploit receptors possessing non-conventional pharmacological profiles and 
unique regulatory mechanisms for improved therapeutic intervention. These perspectives are broad, 
ranging from stress-related disabilities to the treatment of stroke, epilepsy, alcohol intoxication, and 
drug dependency. However, much remains to be learned about how these receptors are regulated and 
how they interact with membrane proteins and intracellular effectors. The other major population of 
extrasynaptic GABAARs, containing the α5 subunit, also offer promise as a target for improving 
intellectual disabilities, memory functions, and cognition. However, as seen with the analysis of 
α5(H105R) mutant mice (Box 3), care has to be taken in the interpretation of behavioral performance 
in mice. 
The molecular heterogeneity of GABAAR subtypes provides the substrate for differential 
transcriptional and translational regulation. Much remains to be learned about how post-translational 
regulation impacts on the trafficking and function of specific receptor subtypes, and how the presence 
or absence of a defined subunit changes this regulation. One might speculate, for example, that the 
heterogeneity of β subunits, which are associated with multiple α subunits, adds to the regulation of 
GABAAR function, because the β subunits are differentially targeted by protein kinases and 
phosphatases (Houston et al., 2008). In contrast, phosphorylation of the γ2 subunit might represent a 
mechanism that is common to multiple GABAAR subtypes. Our recent observation that α3-
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GABAARs, but not α1-GABAARs, are selectively targeted to postsynaptic sites to enhance 
GABAergic transmission when intracellular levels of ROS are increased (Accardi et al., 2014) 
provides a striking example of GABAAR subtype-specific regulation to adjust the strength of 
inhibition in response to a specific stimulus. Uncovering the underlying mechanisms of this specific 
adaptation will help in understanding the difference between α3-GABAARs and α1-GABAARs. 
Furthermore, considering that α1-GABAARs, α2-GABAARs and α3-GABAARs constitute the vast 
majority of postsynaptic GABAARs, it will be essential to unravel their distinguishing features, which 
require them to be differentially expressed and targeted to distinct subcellular sites. As a first step 
towards this goal, a proteomics analysis of GABAergic PSDs, and/or the characterisation of the 
interactome of each main GABAAR subtype, would provide an exhaustive list of signaling pathways 
involved in their trafficking and synaptic function. 
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